1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2007, Issue 2
  5. Article
Volume 2007, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

A total of 78,428 blood units collected by the Blood Donor Unit, Hamad Medical Corporation, Doha, from the multinational donors of Qatar (28,622 Qatari nationals donors and 49,806 Non-Qatari donors) in the period January 1994 to Dececember 2001 were screened for hepatitis markers. About 10,382 units (13.2%) were discarded because of positivity for one or more hepatitis markers; 769 units (0.9%) were positive for hepatitis-B surface antigen (HBsAg), 8516 units (10.9%) were positive for hepatitis-B core antibodies (HBcAb) and 1097 units (1.39%) were positive for hepatitis C (HCV) antibodies. There was no significant difference between the rate of positivity for HBcAb and HBsAg in indigenous Qataris and Non-Qataris despite a slightly higher rate ofpositivity for HCV antibodies in the Non-Qatari group. An outstanding finding was the significantly high rate of positivity for HCV antibodies in Egyptian donations (11.2%), which accounted for 31.2% of all discards for the Non-Qatari group. As the Blood Donor Unit at HMC is the only blood collection center in Qatar it is assumed that the results could be representative of the country as a whole.

© 2007 Fawzi, Al Hilali, Al Malki, Al Matawa, Yousef, Ali Bin Ali, Al Mansour, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2007.2.16
2007-11-01
2024-04-18
Loading full text...

Full text loading...

References

  1. Regan, Patricia Hewitt, John, A.J. Barbara, Marcella Contreras, Fiona AM. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. BMJ. 2000; 320:7232:403–406.
     [Google Scholar]
  2. Jay E. Menitove Transfusion-Transmitted Infections: Update. Seminar in Hematology. 1996; 33:4:290–301.
     [Google Scholar]
  3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Eng J Med. 1996; 334:26:1685–1690.
     [Google Scholar]
  4. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hoi DE, O'Brien SE, Sher G. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T- cell lymphotropic viruses in blood donors in Canada, 1990- 2000. CMAJ. 2003; 169:8:767–773.
     [Google Scholar]
  5. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996. JAMA. 2000; 248:2:238–240.
     [Google Scholar]
  6. Adrian M, Di Bisceglie . Hepatitis C (Seminar). Lancet. 1998; 351::351–355.
     [Google Scholar]
  7. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, Gilcher RO, Kleinman SH, Matijas L, Thomson RA. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA. 1996; 275:13:995–1000.
     [Google Scholar]
  8. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C Transfusion. 1994; 34:2:135–137.
     [Google Scholar]
  9. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edeln R. Risk factors associated with a high seroprevalence of hepatitis virus infection in Egyptian blood donors. Am J Trop Med & Hyg. 1993; 49:4:440–447.
     [Google Scholar]
  10. Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad Pana A, Rocchi G. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol. 1995; 283:2:239–244.
     [Google Scholar]
  11. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, et al., Hepatitis C in a community in Upper Egypt: 1. Crosssectional survey. Am J Trop Med Hyg. 2000; 63:5-6:236–241.
     [Google Scholar]
  12. El Zayedi AR, Selim O, Ibrahim EH, Hamdy H, Dabbous H, Ahdy A, Moneim SA. Does schistsomiasis play a role in the high sero-prevalence of HCV antibody among Egyptians? Trop Gastroenterol. 1997; 18:3:98–100.
     [Google Scholar]
  13. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C and E viruses in residents in an Egyptian village in The Nile Delta: A pilot study. Am J Trop Med Hyg. 1996; 57:3:251.
     [Google Scholar]
  14. Arthur RR, Hassan NF, Abdallah MY, el- Sharkawy MS, Saad MD, Hackbart BG, Imam IZ. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg. 1997; 91:3:271–284.
     [Google Scholar]
  15. Abdel Wahab MF, Zakaria S, Kamel M, Abdel Khaliq MK, Mabrouk MA, Salama H, Esmat G, Thomas DL, Strickland GT. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 1994; 51:5:563–567.
     [Google Scholar]
  16. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui Khurshid M. Epidemiology of blood-borne viruses: A study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health. 1996; 27:4:703–706.
     [Google Scholar]
  17. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002; 52:9:398–402.
     [Google Scholar]
  18. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (ant-HCV) in Madurai, South India. Indian J Med Sci. 2000; 54:7:270–230.
     [Google Scholar]
  19. Jain A, Rana SS, Chakravarty P, Gupta PK, Murthy NS, Nath MC, Gururaja S, Chatturvedi N, Verma U, Kar P. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol. 2003; 18:7:695–297.
     [Google Scholar]
  20. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarath , Nanu A. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease, med Virol. 1997; 51:3:167–174.
     [Google Scholar]
  21. Garag S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol. 2001; 44:4:409–412.
     [Google Scholar]
  22. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6:5-6:1114–1116.
     [Google Scholar]
  23. Albert M Lema, Edmundo A. Cox Hepatitis C Antibodies among Blood Donors in Qatar. Vox Sang. 1992; 63::237.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2007.2.16
Loading
  • Article Type: Research Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error